|
⚲
|
| Keyboard |
| Turka Laurence A
✚
|
|
|---|---|
| CIK # | 0001800952 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001800952] | |
| 4 | [0001800952] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Turka Laurence A | |
| Rubius Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2023-01-31 | Option exercise | 8,625 | ||
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2023-01-31 | Sell | 2,593 | $0.24 | 622 |
|
Rubius Therapeutics Inc RUBY
Restricted Stock Units · derivative
|
2023-01-31 | Option exercise | 8,625 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Restricted Stock Units · derivative
|
2023-01-29 | Option exercise | 7,438 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2023-01-29 | Option exercise | 7,438 | ||
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2022-02-01 | Sell | 2,517 | $6.57 | 16,537 |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2022-01-31 | Grant | 143,750 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Restricted Stock Units · derivative
|
2022-01-31 | Grant | 34,500 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Restricted Stock Units · derivative
|
2022-01-29 | Option exercise | 7,438 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2022-01-29 | Option exercise | 7,438 | ||
|
Rubius Therapeutics Inc RUBY
Restricted Stock Units · derivative
|
2021-01-29 | Grant | 29,750 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2021-01-29 | Grant | 131,250 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2020-01-31 | Grant | 350,000 | $0.00 |